Pharmafile Logo
Pharmafocus logo
Advanced Search
kelner_rob_070427

Valeant hires attorney and crisis management firm to handle bad US PR

December 17, 2015
Medical Communications, Sales and Marketing Robert Kelner, Valeant, Vianovo. Covington & Burling

Valeant has retained attorney Robert Kelner, a partner at the law firm Covington & Burling, to help the beleaguered pharma …

Appointment
csm_297_1444449899_5ce719038f

US ‘star’ Bradner to head Novartis Institute of Biomedical Research

December 17, 2015
Research and Development James Bradner, Jay Bradner, Mark Fishman, Novartis, Novartis Institute for Biomedical Research

Novartis has hired James ‘Jay’ Bradner, from Harvard’s Dana-Farber Cancer Institute, to head its Institutes for Biomedical Research from 1 …

Appointment
Sovaldi bottle

Gilead’s Sovaldi wins Drug Discovery of the Year Award

December 16, 2015
Research and Development British Pharmacological Society, Gilead, Gilead Sciences, hepatitis C, sofosbuvir, sovaldi

Gilead Science’s hepatitis C treatment Sovaldi has been awarded the British Pharmacological Society’s prestigious Drug Discovery of the Year 2016. …

News
john_sentamu

Archbishop of York to become patron of national charity tackling superbugs

December 16, 2015
antibiotic resistance

Antibiotic Research UK (ANTRUK), a charity founded in 2014 to save modern medicine from the onslaught of superbugs, has announced …

Appointment
jessica_fine

MSD UK appoints Jessica Fine as executive director of external affairs

December 16, 2015
Medical Communications Jessica Fine, MSD

MSD has appointed former Lexington Health boss Jessica Fine to lead its external affairs team in the UK from April …

Appointment

New final NICE guidance on AbbVie, BMS, Pfizer and Roche drugs

December 16, 2015
Sales and Marketing BioMarin Pharma, Enbrel, Humira, Ikervis, MPS IVa, NICE, NICE guidance, Orencia, RoActemra, Santen, apremilast, ciclosporin, dry eye syndrome, juvenile idiopathic arthritis, otezla, psoriatic arthritis, vimizin

NICE has published final guidance on several drugs, approving therapies for juvenile idiopathic arthritis, dry eye disease and Morquio A …

News
tony_gardiner

Avacta appoints Tony Gardiner as chief financial officer

December 16, 2015
Medical Communications Avacta Group

Avacta Group, the developer of Affimer biotherapeutics and research reagents, has appointed Tony Gardiner as group chief financial officer. Gardiner …

Appointment
Return on investment

Analysts say pharma R&D returns challenged by drag of high costs

December 16, 2015
Research and Development, Sales and Marketing R&D, drug development, research and development, return of investment, sales, sales forecasts

The projected rate of return on pharma industry research and development has more than halved since 2010, from 10.1% to …

News
juan_luciano

Juan Luciano appointed to Eli Lilly board

December 16, 2015
Medical Communications Eli Lilly

The board of directors of Eli Lilly has elected Juan Luciano as a new member, effective February 1 2016. Luciano …

Appointment

AstraZeneca to acquire Takeda’s respiratory franchise

December 16, 2015
Manufacturing and Production, Research and Development AstraZeneca, China, Takeda, investment, respiratory

AstraZeneca and Takeda have agreed a multi-million pound deal for AZ to acquire the Japanese firm’s core respiratory business, including …

News
clinical_trial-web

Pharma deals crucial to cutting R&D costs

December 16, 2015
Research and Development GlobalData, R&D, drug development, pharma, research and development

With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster …

News
Monopoly board tax

Pharma companies warned on patent box changes

December 16, 2015
Research and Development R&D, patent box, pharma, research and development, tax

Proposed Government changes to legislation will require businesses to track and trace all R&D expenditure if they want to continue …

News
R&D researcher

More breakthroughs in cancer pose the question: Who pays for them?

December 16, 2015
Research and Development Cancer, drug access, immunotherapy, oncology

The molecular revolution over the last decade has done much to help turn cancer into an illness that can be …

Feature
NHS sign

NICE rejects BMS cancer drug in draft guidance

December 16, 2015
Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, NHS, NICE, lung cancer, nivolumab, non small cell lung cancer, non-small cell lung cancer, opdivo

In draft guidance, NICE has chosen not to recommend Bristol-Myers Squibb’s Opdivo for the treatment of locally advanced or metastatic …

News
Kadcyla

NICE says no to NHS funding for Kadcyla

December 16, 2015
Research and Development, Sales and Marketing Breast Cancer Now, Kadcyla, NHS, NICE, Roche, advanced breast cancer, breast cancer

NICE has turned down Roche’s application for NHS funding for Kadcyla as a treatment for a type of advanced breast …

News

Precious Cells Group appoints David Huse in expansion push

December 15, 2015
Medical Communications, Research and Development Stem cells, precious cells group

Precious Cells Group, a UK-based international provider of stem cell storage and related technologies, has announced the appointment of commercial …

Appointment
amgen_hq

Amgen buys back rights to three drugs from GSK

December 15, 2015
Research and Development, Sales and Marketing Amgen, GSK

Amgen has announced that it will reacquire the rights to three products in 48 countries from GSK, as it seeks …

News
AZ Macclesfield site

AstraZeneca invests £75m to future-proof production facilities

December 15, 2015
Manufacturing and Production AstraZeneca, manufacturing, production

AstraZeneca says it will invest £75m to future-proof a key production facility in Macclesfield, Cheshire. The upgrade to the 48-year-old …

News
Sanofi BI logos

Pharma giants Sanofi and Boehringer negotiate deal to swap assets

December 15, 2015
Business Services, Manufacturing and Production, Sales and Marketing Andreas Barner, Boehringer, Boehringer Ingelheim, Merial, Sanofi, olivier brandicourt

Two of the world’s biggest pharma companies – Sanofi and Boehringer Ingelheim – have entered into exclusive negotiations to swap …

News
Malaria mosquito

GSK in malaria collaboration with Comic Relief

December 15, 2015
Manufacturing and Production Comic Relief, GSK, corporate social responsibility, csr, malaria

GSK and UK-based charity Comic Relief have launched a five-year partnership to fight malaria and improve health in five countries …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026